Back to Search Start Over

Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations From EMBARK.

Authors :
Shore ND
De Giorgi U
Freedland SJ
Source :
The Journal of urology [J Urol] 2024 Sep 03, pp. 101097JU0000000000004228. Date of Electronic Publication: 2024 Sep 03.
Publication Year :
2024
Publisher :
Ahead of Print

Details

Language :
English
ISSN :
1527-3792
Database :
MEDLINE
Journal :
The Journal of urology
Publication Type :
Editorial & Opinion
Accession number :
39226589
Full Text :
https://doi.org/10.1097/JU.0000000000004228